Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: a risk-benefit analysis of a large phase III study. (Q45994103)
Jump to navigation
Jump to search
scientific article published on 25 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: a risk-benefit analysis of a large phase III study. |
scientific article published on 25 May 2009 |
Statements
1 reference
Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: a risk-benefit analysis of a large phase III study. (English)
1 reference
Janusz Rolski
1 reference
Giorgio V Scagliotti
1 reference
Keunchil Park
1 reference
Shekar Patil
1 reference
Tuncay Goksel
1 reference
Renato Martins
1 reference
Steven J M Gans
1 reference
Carla Visseren-Grul
1 reference
Patrick Peterson
1 reference
25 May 2009
1 reference
45
1 reference
13
1 reference
2298-2303
1 reference